Food and Drug Administration. Questions and Answers about FDA's Actions on Dietary Supplements Containing Ephedrine Alkaloids. 24 June 2006. www.fda.gov
Hasegawa A, Yoshino M, Nakamura H, et al. Identification of inhibitory component in cinnamon--O-methoxycinnamaldehyde inhibits CYP1A2 and CYP2E1. Drug Metab Pharmacokinet. 2002;17(3):229-36.
Japanese Ministry of Health, Labour and Welfare. 23 June 2006. www.mhlw.go.jp
Murayama T, Yamaguchi N, Iwamoto K, et al. Inhibition of ganciclovir-resistant human cytomegalovirus replication by Kampo (Japanese herbal medicine). Antivir Chem Chemother. 2006;17(1):11-6.
Nagai T, Arai Y, Emori M, et al. Anti-allergic activity of a Kampo (Japanese herbal) medicine "Sho-seiryu-to (Xiao-Qing-Long-Tang)" on airway inflammation in a mouse model. Int Immunopharmacol. 2004 Oct;4(10-11):1353-65.
Tong Y, Zhang NX, et al. [Protective and therapeutic effects of Shugan Lifei Recipe on rats with asthma under stress and the mechanisms] Zhong Xi Yi Jie He Xue Bao. 2005 Sep;3(5):391-6. Chinese.
Yafune A, Cyong JC. Population pharmacokinetic analysis of ephedrine in Kampo prescriptions: a study in healthy volunteers and clinical use of the pharmacokinetic results. Int J Clin Pharmacol Res. 2001;21(2):95-102.
Yamada H, Nagai T. In vivo antiinfluenza virus activity of Kampo medicine Sho-seiryu-to through mucosal immune system. Methods Find Exp Clin Pharmacol. 1998 Apr;20(3):185-92.
Yamasaki K, Kajimura K, Nakano M, et al. Effects of preparations of Chinese medicinal prescriptions on digestive enzymes in vitro and in vivo. Biol Pharm Bull. 1998 Feb;21(2):133-9.
Yamashiki M, Asakawa M, Kayaba Y, et al. Herbal medicine "sho-saiko-to" induces in vitro granulocyte colony-stimulating factor production on peripheral blood mononuclear cells. J Clin Lab Immunol. 1992;37(2):83-90.